What's breaking now, across thousands of outlets.
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
A study of how cells repair radiation-induced genetic damage offers clues to why some people develop cancer early in life or more than once.
(MedPage Today) -- Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebola outbreak, particularly in the eastern province of North Kivu where cases have…
A genetic testing program that helps rule out a stem-cell donor due to a genetic risk for developing leukemia was pioneered in the Maritimes, and is helping to improve cancer care.
Approach to treating high blood pressure ‘not fit for purpose’, say researchers, with 59% of cases undiagnosed Only half of people being treated by a GP for high blood pressure in England have it…
Even with preserved memory, older adults with higher amyloid-beta levels face greater risks of future brain atrophy. A new study highlights that this amyloid-driven shrinkage accelerates faster in…
Though the name of the $100 million donor was not released, a news release about the donation said they had a "personal connection" to cancer.
